Halozyme Therapeutics/ US40637H1095 /
2024-07-26 9:59:55 PM | Chg. +0.28 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
56.23USD | +0.49% | 24,769 Turnover: 1.39 mill. |
-Bid Size: - | -Ask Size: - | 57.09 | 55.63 |
Business description
-
Management board & Supervisory board
CEO |
---|
Helen Torley |
Management board |
Nicole LaBrosse, Mark Snyder, Michael J. LaBarre, Chris Wahl, Cortney Caudill, Tram Bui, Gary Grote, Amy Fox, Steve Knowles, Christopher Bryant, Kristin Schwartzbauer |
Supervisory board |
Jeffrey W. Henderson, Jean-Pierre Bizzari, Barbara Duncan, Matthew L. Posard, Connie L. Matsui, Moni Miyashita, Bernadette Connaughton, Helen Torley |